Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2012

View Archived Issues

New ESC guidelines recommend use of ticagrelor

Symphogen licenses Sym-004 to Merck KGaA

FDA continues review of crofelemer NDA beyond PDUFA date

ValiRx reports data on VAL-201 for breast cancer

Novel HDAC inhibitors prepared at Dana Farber Cancer Institute

CSIR patents novel agents for cancer

Glenmark Pharmaceuticals prepares new MPGES-1 inhibitors

Novel DGAT1 inhibitors synthesized by Merck & Co.

Scientists at BioRelix present new flavin derivatives

Phase II zabofloxacin results presented at ICAAC

Generon begins clinical studies of IL-22 product

FG-3019 safe and well tolerated in phase II study in IPF

Aileron Therapeutics reports on new therapeutic drug program

NeurOp receives NIH funding for ischemia research

PM-01183 receives positive opinion for orphan drug status in E.U.

Sanofi develops new 11-beta-HSD1 inhibitors for the treatment of diabetes

InSite Vision completes enrollment of DOUBle study

Janssen makes submissions to the FDA for two different Xarelto sNDAs

SFJ and Pfizer sign agreement to codevelop treatment for advanced NSCLC

Atu-111 shows efficacy in preclinical model of acute lung injury

Phase I/II trial of Astex's HSP 90 inhibitor begins

Cedars-Sinai Heart Institute receives funding to further study cardiac stem cells

AstraZeneca discontinues development of candidate in obesity collaboration with Palatin

Actinium to begin screening patients for second cohort of phase I/II trial in AML

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...